Venture Life Snaps Up Netherlands’ Pharma Source

Consumer Health player Venture Life is expanding its reach in mainland Europe with the acquisition of Dutch medical devices specialist Pharma Source.

Businessman_Jigsaw
• Source: Shutterstock

UK-based consumer health player Venture Life Group has expanded its product portfolio and broadened its reach in Europe with the acquisition of Pharma Source BV for an initial €5.23m ($5.81m), plus a deferred contingent consideration of up to €1.27m.

Netherlands-based development and distribution firm Pharma Source markets a range of medical devices across many therapeutic areas including fungal nail infections, wart removal and women's health. It owns various medical...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business

Alliance Pharma’s New Owners Will Instill ‘More Consumer-Oriented Mindset’

 
• By 

Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By 

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

 
• By 

In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.